Your web browser doesn’t have the Flash Player v.9 plugin installed, so this Website can’t be properly viewed.
For full experience, please download the latest Flash plugin at Adobe.com.
Download Adobe Flash Player now.
Quadrivalent human papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine
Getting the first dose of GARDASIL® was an important step in helping to protect against 4 types of HPVGenital HPV (human papillomavirus)About 30 types of HPV are known as genital HPV since they affect the genital area.
Get More Information
See Full Glossary and the diseases associated with these types like cervical cancerCervical cancerCervical cancer is cancer of the cervix, the lower part of the uterus that connects to the vagina. It is a result of HPV.
Get More Information
See Full Glossary, vaginal and vulvar cancers, and genital wartsGenital wartsGenital warts are usually flesh-coloured growths that are caused by certain types of HPV.
Get More Information
See Full Glossary. Now it’s time to start thinking about the other 2 doses.
As you may already know, GARDASIL® is given as 3 injections (shots) over 6 months (first dose, 2 months, 6 months). Making sure you get all 3 doses will allow you to get the full benefits. So it's important to know when you're due for your next dose.
You’re already taking time out of your busy schedule to get vaccinated with GARDASIL®. So we’d like to help you out by reminding you when it’s time for your next dose.
GARDASIL® is a vaccine indicated in girls and women 9-26 years of age, for the prevention of infection caused by HPV types 6, 11, 16, and 18 and the following diseases associated with these types: cervical cancer, abnormal and precancerous cervical cells, vaginal and vulvar cancers, abnormal and precancerous vaginal and vulvar cells, and genital warts.
GARDASIL® helps prevent these diseases but it does not treat them. And just like all vaccines, GARDASIL® may not fully protect everyone who gets it. GARDASIL® does not protect against all types of HPV. Duration of protection over the long term has not been established. Vaccination with GARDASIL® is not recommended during pregnancy.
Like all vaccines, GARDASIL® may cause some side effects. GARDASIL® has been shown to be generally well tolerated in adults and children as young as 9 years old. The most commonly reported side effects in girls and women included pain, swelling, itching, bruising and redness where the shot was given. Fever, nausea, dizziness, headache and vomiting were also reported. Allergic reactions may occur.
Even if you get vaccinated with GARDASIL®, it is still important to continue having regular Pap tests.
Only a healthcare professional can decide if GARDASIL® is right for you or your daughter.
This site is intended only for residents of Canada. This Website is for information purposes only.
®Registered Trademark of Merck & Co., Inc. Used under license.
©2009 MERCK FROSST CANADA LTD. All rights reserved.
HPV-09-CDN-84140570-WEB